Latest Research

New Antibody Discovered

Clinical Trials


Medical Journal Articles

  • Effect of long-term continuous methimazole treatment of hyperthyroidism: comparison with radioiodine. (May 2005) PMID 15879354
  • Transient hyperthyroidism after withdrawal of antithyroid drugs in patients with Graves’ disease. (Feb 2005) PMID 15118273
  • Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism. (Mar 2007) PMID 17374710
  • Treatment for childhood-onset graves’ disease in Japan: results of a nationwide questionnaire survey of pediatric endocrinologists and thyroidologists. (Jan 2007) PMID 17274753
  • Treatment of Graves’ disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study. (Jan 2007) PMID 17218723
  • Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves’ patients. (Dec 2006) PMID 17199435
  • Israeli researchers close in on vaccine for autoimmune diseases (Mar 2006) Israel21c
  • Aberrant expression of the insulin-like Growth Factor-1 Receptor by T-cells from patients with Graves’ Disease (Mar 2007) Journal of Immunology See also PMID 17312178
  • Treatment with inorganic iodine for Graves’ hyperthyroidism (Dec 2006) PMID 17154090
  • Guideline for the treatment of Graves’ disease with antithyroid drug PMID (Dec 2006) 17154077
  • Remission of Graves’ disease during anti-thyroid drug therapy. Time to reconsider the mechanism? PMID (Dec 2006) 17132745
  • Spontaneous hypothyroidism in the follow up of Graves hyperthyroid patients treated with antithyroid drugs. (Oct 2006) PMID 17100026
  • Psychiatric manifestations of Graves’ hyperthyroidism: pathophysiology and treatment options. (2006) PMID 17044727
  • Randomized, double-blind, placebo-controlled trial of long-acting release octreotide for treatment of Graves’ ophthalmopathy. (Dec 2006) PMID 16984988
  • Pharmacological treatments for thyroid eye disease. (2006) PMID 16978034
  • Graves’ hyperthyroidism: how long should antithyroid drug therapy be continued to achieve remission? Article requires subscription located here
  • Long-term follow up after antithyroid drug treatment in Graves’ disease. (Jul 2006) PMID 16916174
  • Propylthiouracil-induced autoimmune syndromes: two distinct clinical presentations with different course and management. (Aug 2006) PMID 16887463
  • TSH receptor antibody measurements and prediction of remission in Graves’ disease patients treated with minimum maintenance doses of antithyroid drugs. (Aug 2006) PMID 16820704
  • Acute myocardial infarction during high-dose methylprednisolone therapy for Graves’ ophthalmopathy. (Apr 2006) PMID 16791713
  • What is the evidence behind the evidence-base? The premature death of block-replace antithyroid drug regimens for Graves’ disease. (Jun 2006) PMID 16728536
  • The rationale for B lymphocyte depletion in Graves’ disease. Monoclonal anti-CD20 antibody therapy as a novel treatment option. (May 2006) PMID 16645007
  • Successful use of iodine and levothyroxine to treat Graves’ disease in a pregnant patient with allergy to antithyroid drugs and high thyrotropin-binding inhibitor immunoglobulin after radioiodine therapy. (Dec 2005) PMID 16405411
  • Researchers identify factor in pathogenesis of Graves’ disease (Mar 2007) Harbor-UCLA via EurekaAlert
  • Cracking open the black box of autoimmune disease: Notes on FOXP3 and PTNP22 (Jan 2007) MIT via EurekaAlert
  • Inhibiting production of IP4 might lead to blocking defective T cell development, possible therapies for immune disorders (Apr 2007) Scripps via EurekaAlert
  • Autoimmune Innovations – On the Horizon Autoimmune Innovations (Feb 2007)
  • New Molecular Path to Fight Autoimmune Diseases Discovered by Penn Researchers Medical News Today (Mar 2007)

Leave a Reply